hand DCOH

Related by string. * HAND . HANS . HAN . Hand . Haner . Haning . Hans . hans . HANs . HAN' . Han : Cool Hand Luke . Hans Christian . Hand Held Products . weapons inspector Hans . Helping Hand . later Han vigilantes . hand . inspector Hans Blix . Hee Won Han . composer Hans Zimmer . han . hand lettered . hand sanitizing gel . J Hand Surg . Hans Werner Sinn . inspectors Hans Blix / : DCOH . #.# DCOH * hand DCOH cushion *

Related by context. All words. (Click for frequent words.) 75 DCOH 65 Fitch BBB medians 64 category medians 60 #.# DCOH 59 Sales Outstanding DSO 58 LTM EBITDA 58 sales outstanding DSOs 57 pro forma MADS 57 Sales Outstanding DSOs 57 MADS coverage 56 Conversion Cycle 56 outstanding DSOs 56 fiscals #-# 55 NOI DSCR 55 EBIDA 54 accounts receivable DSO 54 pro forma MADS coverage 54 outstanding DSO 54 LTM EBITDA ratio 54 DSOs 53 undepreciated book 53 Fitch DSCR 53 stressed DSCR 53 Total Leverage Ratio 53 BBB medians 53 operating EBIDA 53 #.#x #.#x [002] 52 Realized Earnings 52 service MADS 52 Pro forma Adjusted EBITDA 52 #.#x #.#x [001] 51 adjusted EBITDAR 51 Ps.3 51 LTM adjusted EBITDA 51 service MADS coverage 50 DSCRs 50 Inventory Turnover 50 undepreciated book capital 50 EBTIDA 50 #.#x #.#x #.#x [002] 50 ended September# 50 borrowable resources 50 #.#x [003] 49 ROAA 49 efficiency ratio teb 49 Consolidated EBITDA 49 maturity WAM 49 #.#:#.# [003] 48 #.#x #.#x #.#x #.#x [001] 48 AA medians 48 #.#cps [002] 48 CAPITAL RESOURCES 48 Realised Earnings 48 Ps.1 #.# 48 voluntary prepayments 48 Total Capitalization 48 marketable securities totaled 48 TCE TA 48 pro forma adjusted EBITDA 48 THE JEAN COUTU 48 unreserved undesignated fund 47 Unitholder distributions 47 AFFO payout ratio 47 FYE# 47 MADs 47 TTM = trailing 47 coverage ratios DSCRs 47 revolver borrowings 47 ascompared 47 Leverage ratios 47 Claims Payable 46 undrawn commitments 46 unreserved undesignated 46 Capital Employed 46 FFO payout ratio 46 unreserved undesignated general 46 TCE ratio 46 Tangible Common 46 LTL tonnage 46 cash flows 46 EBITDA1 46 Adjusted EBIDTA 46 Adjusted EBITDA1 46 average assets ROAA 46 undrawn revolver 46 FYE# FYE# 46 Ps.7 46 un levered 46 LIQUIDITY AND 46 LTM 46 ILU occupancy 46 Factor WARF 46 Coverage Ratio 46 #.#X [003] 46 #E EBITDA 46 Positive Rating Outlook 46 Normal Cooling Degree 46 Notching Criteria 46 putable 46 Normal Heating Degree 45 Statutory surplus 45 A#/P# 45 MCCSR ratio 45 average equity ROAE 45 NSLIJ 45 Invested assets 45 Nonperforming assets totaled 45 LTM Adjusted EBITDA 45 accruing restructured 45 #.#x #.#x #.#x #.#x [003] 45 HRHS 45 accruing loans 45 Zometa hazard 45 Taberna IX 45 Funded Debt 45 ROACE 45 Interest Coverage Ratio 45 Nonaccrual loans totaled 45 Solvency ratio 45 borrowable funds 45 FAD payout ratio 45 capital employed ROACE 45 E1 #Mn 45 Nonperforming Assets Nonaccrual loans 45 EDITDA 45 Quarterly Periods 45 OCF margin 45 minus TEUR 45 WORKING CAPITAL 45 CAD#.# billion 45 undepreciated assets 45 Interest Expense Interest expense 45 #.#x MADS [001] 45 undrawn revolving credit 45 normalized FFO 45 -Bussewitz 45 BB IDR 45 Best Capital Adequacy 45 Fitch AAAmmf rating 44 coverage ratios DSCR 44 -# TEUR 44 subordinate lien bonds 44 nonaccruing loans 44 FHLB advances decreased 44 A#.# #.#c 44 Rs4 #cr 44 LFQ gross 44 SEK -#.# [002] 44 covenant headroom 44 Nonperforming loans totaled 44 TEB adjustment 44 GROUP PJC INC. Consolidated 44 BBB + rating 44 n Cooling Degree 44 EUR -#.# -#.# [001] 44 #.#x #.#x [003] 44 EUR -#.# [001] 44 NSE Volatility Index 44 normalized EBITDA 44 Non GAAP adjusted EBITDA 44 Fully Taxed EPS 44 Invested Capital 44 #.#x [007] 44 CDO financings 44 Ebidta 44 binary restenosis 44 CFFO 44 of#.# [003] 44 EBITDAR 44 HSNSI stood 44 SHFAs 44 FY#E EV EBITDA 44 d Calculated 44 comparably rated 44 - -Davis Jayalath 44 CY#E EPS 44 Annualized ROE 44 LIBOR + 44 MBS AFS increased 44 FHLB borrowings decreased 44 accompanying electrolyte abnormalities 44 cash equivalents marketable securities 44 millioncompared 44 dosed intravenously 44 Unlevered free 44 Weighted Weighted average 44 Stockholder equity 44 quarter offiscal 44 Pro forma adjusted EBITDA 44 -DUET WITH 44 pro forma EBITDA 44 INR1 #m 43 Recurring FFO 43 noninterest expense totaled 43 nonperforming loans NPLs 43 NTKM 43 SBLIC 43 excluding Alumbrera 43 Secured Debt 43 #.#x DSCR 43 #.#:# #.#:# [001] 43 BBB IDR 43 cash equivalents 43 SEK -#.# -#.# [003] 43 Constant Prepayment Rate 43 unreserved fund 43 unbilled revenue 43 loan chargeoffs 43 Liquidity Ratio 43 SEK -#.# [001] 43 Annualized Return 43 Available Seat Kilometres ASKs 43 Weighted Average Rating 43 Cash Flow Cushion 43 Repricing Gap 43 CDAI score 43 operating income1 43 EBIDTA margin 43 Leverage ratio 43 SmartGrowth Deposits 43 -Steamie 43 HGNSI stood 43 Noninterest expense decreased 43 BBB-/BB + 43 Halotron revenues 43 Long Term Debt 43 EUR#.#b 43 MYR#.# [005] 43 downstreamed 43 Current Ratio 43 #.#-#.# bln dkr [002] 43 INR#.#m [002] 43 expenses totaled Ps 43 5 Yr Avg 43 totaled MEUR 43 INR#.#bn [004] 43 unfunded actuarial liability 43 '#E EPS 43 BVPS 43 Interest expense decreased 43 Loss Severity 43 #.#/BOE [002] 43 FCGH 43 #.#/diluted share 43 annualized ROA 43 FCF = 43 adjusted Ebitda 43 Chargeoffs 43 Normalized FFO 43 USOGP 43 FFO FFO 43 undrawn revolver capacity 43 normalized FFO guidance 43 #.#bln rbl [003] 43 Adjusted EBITDAX 43 policyholder surplus 43 unleveraged yield 43 was#.# 43 Q2 FY'# 43 Stable Rating Outlook 43 MEUR -#.# 43 affirmations reflect 43 solvency ratio 43 CHF #'#'# 43 Asset Impairment Charge 43 Negative Rating Outlooks 43 pulmonary exacerbations 42 PDP MLR 42 BBB rating 42 ROAE 42 Unaudited Unaudited Audited 42 ATCF 42 EBITDAR margin 42 excluding reimbursables 42 R# 4m [001] 42 loan amortizes 42 Earning Per Share 42 increaseof 42 reserve reestimates 42 Caparra Hills 42 CIP totals 42 Delinquency Rate 42 Leverage Ratio 42 pulmonary capillary wedge 42 Medicare Advantage MLR 42 Capital Lease Obligations 42 adjusted EBITDA 42 MNMC 42 standardized distributable cash 42 prioryear 42 -SEAMUS BRENNAN 42 EPADS estimates 42 covenant ratios 42 By GlobalGrind Staff 42 balance UPB 42 % Confidence Interval 42 BIS Tier 42 principal paydowns 42 EBITDARM 42 monthsended 42 CHF #.#M 42 REGULATORY CAPITAL DATA 42 OTTI charges 42 FDIC indemnification 42 Consolidated Cash Flow 42 Search BostonHerald.com 42 preintervention 42 pro forma basis 42 normalized EPS 42 EBITDA 42 Sees FY# revs 42 TFG CLO investments 42 Uncollected trash piled 42 #-# bps 42 SBIC leverage 42 assets ROAA 42 Raises Guidance AMEX DLA 42 Accruing loans past 42 Exchangeable Share Ratio 42 SEK1 #m 42 Amsurg NASDAQ AMSG 42 nine monthsended 42 Commments posted several 42 Payments SFAS #R 42 x #mm WDH [002] 42 EBITDA EBITDAM EBITDAR 42 Total Liabilities #,#.# #,#.# [001] 42 sameperiod 42 noncovered loans 42 deemed uncollectible 42 excluding AOCI 42 www.willbros.com 42 operating netbacks 42 QR #.#bn 42 Adjusted OIBA 42 Assessed valuation AV 42 AND LIQUIDITY 42 NAIC RBC 42 borrowings repayments 42 Unlevered 42 Outlays totaled 42 Ambac insures 42 PMPM basis 42 Ps.6 42 normalized EBIT 42 Measurable precipitation 42 LifePoint Hospitals NASDAQ LPNT 42 .#:# 42 Adjusted FFO 42 Our PMVS 42 Soil moisture ranged 42 revenues excluding nonrecurring 42 BRE Properties BRE 42 Normalized EBITDA 42 Rebates receivable 42 cash flow 42 factor WARF 42 ACR ReTakaful SEA 42 Annualised 42 Dividend Payout Ratio 42 Net chargeoffs 42 B/RR3 42 mL/min/#.# m2 42 recourse indebtedness 42 B + RR3 41 #.#per [002] 41 http:/bit.ly/dkzbIa 41 #E EPS 41 Reviewed Audited 41 Total Tangible Assets 41 Core FFO 41 SOIR readings 41 loan fundings 41 nonperforming loans totaled 41 Qtr Qtr 41 unaccreted discount 41 peak VO2 41 SF CDO 41 PIT receipts 41 RLEC adjusted EBITDA 41 Settlement Date shall 41 Fitch Assigns Initial 41 Negatively impacting 41 INR#.#m [001] 41 Balance Sheet Cash Flow 41 RevPAR ADR 41 Average Assets ROAA 41 JPY8 41 unenhanced rating 41 n#.# [002] 41 #.#Â [002] 41 trailing twelve 41 Consolidated OIBDA 41 Q4 F# 41 unaudited consolidated balance sheets 41 CC/RR6 41 CURRENT LIABILITIES Current 41 PMVS 41 Additionally Fitch affirms 41 nonaccruals 41 DANA HOLDING CORPORATION Consolidated 41 SmartGrowth Loans 41 #.#x respectively 41 proforma basis 41 adjusted distributable cash 41 inhospital mortality 41 Unfavourable Changes 41 -GNS seismologist 41 gross NPL ratio 41 Unified Parkinson Disease 41 accumulated undistributed 41 FY#E FY#E 41 income teb 41 NCO GROUP INC. 41 inhospital 41 ceding commissions 41 Negative Outlooks 41 LIFO adjustment 41 Non GAAP Disclosures 41 ZAR#.# billion [002] 41 DSRF 41 CAD#.# [002] 41 #E #E [003] 41 payor mix 41 Dhs1 #m 41 Earnings Hindsight 41 Doubtful Accounts 41 unaudited audited 41 RO#.# [006] 41 MXN#.# billion [002] 41 non recourse RISPERDAL 41 coverage ratio DSCR 41 ended -David Gozal 41 Consolidated Leverage Ratio 41 estimated undiscounted 41 repo counterparties 41 Negative Rating Outlook 41 rebased amounts 41 Accruing Loans 41 margin teb 41 Renegotiated loans 41 LAE reserves 41 CI #.#-#.# [001] 41 receivables securitization facility 41 Still Accruing 41 '#E 41 Its ROA 41 placebo PBO 41 COGP 41 #Q'# 41 Balance Sheet Assets 41 MADS 41 Revenue Trades DARTs 41 Current Maturities 41 assigned Negative Outlook 41 reconciles EBITDA 41 OPEB liability 41 Standardized distributable cash 41 NOTES Applicable 41 Topsoil moisture supplies 41 Covered Loans 41 #.#ps 41 Adjusted EBTIDA 41 Accruing loans delinquent 41 Heating Degree 41 Individual Annuities segment 41 - Total Current LiabilitiDouglas H. McCorkindale 41 payout ratio 41 nonGAAP 41 FY #E [002] 41 SEK -#.# -#.# [001] 41 #.#X [002] 41 EUR #,# Mio 41 unfavorable variance 41 - Liabilities [003] 41 annualizes 41 UHSEC 41 Unsecured Revolving Credit 41 FY#E EPS [002] 41 F1 ind 41 Roddick Petitbois 41 TEUR -# 41 LIFO inventory adjustments 41 GANs 41 marketable securities 41 Successor Period 41 #.#x MADS [002] 41 Efficiency Ratio 41 Taxable assessed valuation 41 BB-/RR1 41 MEP Joint Venture 41 Consolidated adjusted EBITDA 41 - ASSETS Cash [002] 41 FY#F 41 Tear Sheet 41 serum sodium concentration 41 TRANs 41 Q2 F# 41 CIRe 41 Wireline adjusted EBITDA 41 EBITDAF 41 Payout Ratio 41 1H FY# [002] 41 Distribution Payable 41 accounts receivable balances 41 ANSYS INC. AND 41 Ezcorp NASDAQ EZPW 41 TWD#.# [002] 41 -Hometown Democracy amendment 41 Ps.2 41 - Announce Allot 41 Mavrix Mutual Funds 41 covenant calculations 41 C/RR6 41 IFL chemotherapy regimen 41 -Louise Hawkley 40 cows BCG matrix 40 Metris Master Trust 40 IDR F1 40 #A #A [003] 40 Billable headcount 40 ABL revolver 40 #.#/sh 40 Risk Weighted 40 MARTEN TRANSPORT LTD 40 IDR BB 40 Nifty PCR 40 excluding BIBP 40 balance sheet 40 #.#Â [001] 40 assets RoA 40 thequarter 40 Kt V 40 Ps.4 40 - -Kratofil 40 FQ1 40 pro forma 40 IBNR reserves 40 quarter LFQ 40 BNTB 40 #.#/boe [001] 40 FTE staffing 40 MXN# [001] 40 contractual subordination 40 Nonaccrual Loans 40 DKK #,#,# 40 Ratio BCAR 40 Rating Outlook revision 40 Glory Indigenes Algeria 40 EBITDAC 40 operatingincome 40 RMBS Criteria 40 Tangible stockholders 40 Pro forma EPS 40 amortization EBIDTA 40 IN THOUSANDS 40 HUF 5bn 40 QCR HOLDINGS INC. CONSOLIDATED 40 progression TTP 40 OTTI write downs 40 Negative Rating Watch 40 fiscalyear 40 Warrant Exercise Price 40 Leverage Ratios 40 AND CASH FLOW 40 Vitran NASDAQ VTNC 40 Joseph Piotroski benchmark 40 Stable Outlooks 40 per share1 40 noninterest expense divided 40 nonaccrual loans accruing 40 unrealized losses 40 PTPP 40 invisibles surplus 40 Q2 FY# [001] 40 CY# EPS estimate 40 Lease Losses ALLL 40 Cogent IR 40 MNOK #.# 40 BBB/F2 40 #.#x FY#E EPS [003] 40 ASUR regulated 40 loan originations totaled 40 RSUs vest 40 INR#m [002] 40 Quarter Ended - [005] 40 Suezmax fleet 40 LTV ratios 40 EBITA amounted 40 Wysaske 40 accrual status 40 OREO write downs 40 hedge ineffectiveness 40 RUR#.#bn approx. USD#m [003] 40 SMURFIT STONE CONTAINER CORPORATION 40 Shareholder Equity 40 debentures maturing 40 Adjusted Ebitda 40 theprior 40 nonperforming assets totaled 40 Market Capitalisation 40 unrealized depreciation 40 unitholder distributions 40 GAAP Adj 40 postintervention 40 Total nonperforming assets 40 By NBC# NBC# 40 per enplanement CPE 40 -planting saplings 40 CAD#.# [005] 40 CAD#.# [001] 40 aP S 40 loss NOL carryforward 40 Mature Trend #.# 40 Q3 F# 40 -#.# mg dL [002] 40 consolidated ADV 40 Active Trader DARTs 40 Noninterest expense totaled 40 Pro forma Pro forma 40 expiratory flow 40 c Calculated 40 unamortized discount 40 Operating Cash Flow 40 Pro forma EBITDA 40 SEK -#.# [003] 40 Fixed annuity 40 million1 40 EBITD 40 Wireline EBITDA 40 ZAR#.# [005] 40 Balance Sheet Highlights 40 equity excluding AOCI 40 XLP SPY Relative Strength 40 Pigments segment 40 Receivables Held 40 LBITDA 40 HBeAg seroconversion 40 PLN #.#mn [001] 40 YonY 40 #.#/BOE [001] 40 MARINOL R 40 net chargeoffs 40 undrawn 40 Gross NPAs 40 passenger RASM 40 MENTOR GRAPHICS CORPORATION UNAUDITED 40 LIBOR +# 40 UAAL 40 of#.# [004] 40 Adjusted EBITA 40 - -Distribution BULLETIN DATE 40 Medcath NASDAQ MDTH 40 MFFO 40 fiscal year# 40 defease 40 mainline passenger RASM 40 EV Ebitda multiple 40 Actual Heating Degree 40 NGL margins 40 RUB#.#bn [001] 40 - ASSETS [016] 40 diluted FAD 40 inflows outflows 40 -Gian Carl 40 #.#x FY#E EV EBITDA [001] 40 FAR WEST Soil moisture 40 Fully diluted EPS 40 Adjusted Operating Expenses 40 comparedto 40 -FFK 40 Settle Announce Allot 40 3x 4x 40 voluntary prepayment 40 COMPARATIVE PRELIMINARY TRAFFIC SUMMARY 40 -demystification 40 distributable earnings 40 Divestco generated 40 Sees FY# EPS 40 Kleros RE IV 40 REPUBLIC SERVICES 40 FINANCIAL STATISTICS 40 MMbtu d 40 assets ROA 40 nonperforming assets NPAs 40 EBIDTA margins 40 Dhs2 #m 40 Specialized REITs industry 40 TTM gross 40 overcollateralized 40 Unaudited Audited Unaudited 39 PNNT 39 ECU netbacks 39 #.#x [006] 39 months endedSeptember 39 Invested Capital ROIC 39 Negative Outlook reflects 39 Accruing loans 39 thousand BOEPD 39 rated CAM2 39 Petition Date 39 Kaplan Meier estimates 39 Pro Forma EPS 39 MuniPreferred 39 Petrofund merger 39 Unitrin Direct segment 39 4x 5x 39 MCCSR 39 Capital Adequacy Ratio 39 Lauren Petitbois 39 Recurring EBITDA 39 -PACCAR PCAR 39 Tangible Common Equity 39 adjusted ebitda 39 Convertible Secured Notes 39 -Andrea Seabrook 39 consolidated passenger RASM 39 BSRR 39 NASDAQ CTCM ranks 39 Coverage Ratio EBITDA 39 MEHC 39 Debt Balances 39 MSEK -#.# 39 DHHA 39 Credit Quality Ratios 39 condensed consolidated balance sheet 39 PASI scores 39 Annualized Adjusted EBITDA 39 totaled E#.# 39 b Calculated 39 Impaired loans 39 Lonpac 39 Accrued liabilities #,#,# #,#,# [001] 39 EURO#.# [001] 39 ROCE 39 9M FY# [001] 39 thethird quarter 39 Average Tangible 39 FMBI 39 OTTI charge 39 senior unsecured debentures 39 Items impacting comparability 39 Normalised earnings 39 Rs.#.#cr 39 Sumaya Bell 39 MtM impacts 39 delevered 39 swingline 39 Summarized consolidated 39 Weighted Average Maturity 39 #.#-#.# bln eur [005] 39 Adjusted EBIT 39 International Liftboats 39 calculated creatinine clearance 39 Non accrual loans 39 EPADS estimate 39 Q1 LY 39 nonaccrual loan 39 RVUs 39 OPEB expense 39 amortizes 39 EBITDAO 39 Core noninterest expense 39 REYATAZ r arm 39 BB + RR1 39 Fixed Charge 39 EPADS 39 Transmontaigne Partners 39 Nakheel Sukuk 39 #,# ADMTs 39 f Represents 39 accounts receivable 39 MIICL 39 NEWSPAPER ADVERTISING VOLUME 39 interest margin NIM 39 Sees FY 39 Average Average 39 intersegment eliminations 39 unaudited unaudited unaudited ASSETS 39 #bn reais 39 Previous Corresponding Period 39 Derivative Liabilities 39 NOPAT 39 stockholders equity 39 KZT #.#bn [002] 39 EUR -#.# [002] 39 #.#per diluted 39 Guides Q# 39 mimicked saliva 39 Otter Tail NASDAQ OTTR 39 GAAP EARNINGS 39 debt maturities 39 adjusted OIBDA margin 39 Issuer Default Rating IDR 39 ninemonths ended 39 detectable HCV RNA 39 weighted average 39 phytosterol revenues 39 NBV margin 39 FM Listenership 39 Q1 #F 39 #.#/share [001] 39 postoperative mortality 39 Reinvested earnings 39 earnings pershare 39 Average Stockholders Equity 39 Minimum Continuing 39 WRIT dividends 39 Lubrizol Additives segment 39 Cash Flow Margin 39 INR#.#bn [001] 39 Solvency Score 39 Tangible Equity 39 Libbey AMEX LBY 39 6/share 39 NOL carryforwards 39 nonaccrual loans 39 Adjusted Earnings 39 postvaccination 39 Euro Libor #.# 39 #.#mln rub [007] 39 Pharmacokinetic parameters 39 overcollateralization tests 39 yearago 39 Noncurrent liabilities Long 39 Free Cash Flow 39 Distributable Income 39 - Unaudited Audited [001] 39 #.#x FY#E earnings [002] 39 BRL#.# billion [002] 39 Baa2 rating 39 -Dershwitz 39 RONW 39 Stable Outlook incorporates 39 RO#.# [001] 39 6MW distance 39 CKX NASDAQ CKXE 39 SEK #.#M #.# 39 Adjusted EBITDAR margin 39 FINANCIAL RATIOS 39 Total Risked Based 39 NYSE TPX 39 corresponding reconciliations 39 unlevered 39 offiscal 39 Monro Muffler NASDAQ MNRO 39 EV FCF ratio 39 FTE headcount 39 F4 ind 39 -CANMET Energy 39 Re REMIC transactions 39 YE# [002] 39 NONPERFORMING ASSETS 39 unaudited unaudited audited 39 Capital Ratio 39 RMBS exposures 39 Excluding nonrecurring items 39 Consolidated Adjusted EBITDA 39 Citadel SMaRT 39 Ebitda 39 ay y basis 39 - -Guldeniz 39 Reviewed Restated 39 accreted value 39 Revises Rating Outlook 39 Eurodollar futures yielded 39 adj EPS 39 Leverage Tier 39 Consolidated EBITDA Margin 39 Teekay Offshore Teekay LNG 39 Non accrual 39 FINANCIAL HIGHLIGHTS -MarketWatch Andria Cheng 39 Glenmeadow 39 epkklk# 39 LTGO 39 Prepays 39 fiscal# 39 #.# perdiluted 39 MSEK -# [002] 39 Balance sheet 39 FINANCING ACTIVITIES Increase 39 F# F# [002] 39 Teekay Parent 39 AVAILABLE SEAT KM 39 EPADR estimate 39 International NASDAQ HSII 39 capitalization 39 unannualized 39 SHKPI 39 hemoglobin concentrations 39 Visant consolidated 39 Petacchi clocked 39 Eur #,# 39 By trevor 39 Investors NYSE OHI 39 Endurance Specialty NYSE ENH 39 consolidated PRASM 39 Endologix NASDAQ ELGX 39 EMPLOYEE FUTURE BENEFITS 39 anincrease 39 Normalized EPS 39 Fosburg remembered 39 Operations AFFO 39 BBB + IDR 39 Cleartel 39 amortizes rapidly 39 GBPm GBPm GBPm 39 value ratios LTVs 39 affirmation reflects 39 Prepaid churn 39 Mature Trend 39 D/RR6 39 - ASSETS Current [014] 39 UPC Broadband Holding 39 ALLL 39 Outstanding GOs 39 d Represents 39 EBIDTA 39 OP Unit 39 receivable balances 39 nonaccruing loans accruing 39 Repliform R revenues 39 OLTV ratio 39 Cash cash equivalents 39 VRDPs 39 #.#MM [006] 39 Innerworkings NASDAQ INWK 39 FPTB 39 ROAs 39 TAMUS 39 minimal paydown 39 AAA/V1 + 39 CMBS collateral 39 4/share 39 #.Q# #.Q# 39 -India Kanishka bombing 39 ttm 39 securitization exposures 39 #.# [043] 39 EBITDAX 39 Senior Secured Term 39 Stable Outlook reflects 39 bullishly biased 39 h Represents 39 frame unlevered 39 INR#m [001] 39 b Excludes 39 Westlake Chemical NYSE WLK 39 H1 FY# [001] 39 USc lb 39 nonperforming asset 39 REIT TruPS CDOs 39 timesthree 38 Rs #.# lacs [001] 38 dividend payout ratio 38 ACGL 38 From Operations AFFO 38 IBDQ 38 AXTI 38 Cooling Degree Days 38 GVIC consolidated 38 noncurrent loans 38 TBtu 38 B-/RR4 38 Funded backlog 38 revenues teb 38 rated Baa 38 CASH FLOWS PROVIDED BY 38 adjusted capitalization 38 - CaLou Smit 38 Ultrapetrol Bahamas NASDAQ ULTR 38 Maintain Buy 38 Average dayrate 38 JPY1 #.# 38 Ps.#.# [001] 38 DSR * 38 postdischarge 38 EARNINGS GUIDANCE 38 adv dec ratio 38 JPY2 #.# [001] 38 Scansource NASDAQ SCSC 38 #bp QoQ 38 unabsorbed fixed overhead 38 apnea hypopnea 38 BB BL 38 EMEA CMBS 38 #.#x FY# [001] 38 Index CDAI 38 ABL revolving 38 rating affirmations 38 SELECTED RATIOS 38 CENTRAL Soil moisture 38 invoiced shipment 38 Rating Outlook Negative 38 FY# NPAT 38 LAMR 38 Partially offset 38 Water NASDAQ CWCO 38 GROUP PJC INC.

Back to home page